No, I cannot think like craigos ...my view is :
The data shown so far has being positive, The chairman report is full of programs in trying to fight this disease or giving a longer life expectancy.
The clinical Pipeline is in full operation with heaps of data coming out in the next 12 months, so all shareholders are part of helping 250,000 patients who are diagnosed each year with HER2 negative and HR positive breast cancer pending on positive result with EFTI. Don't forget during the trials its already help participating patients...
Your in a high risk stock like many others in the ASX or Nasdaq which provides higher returns on your investment on positive outcomes.
You have option to invest in other companies on the ASX that ethically would be more to you're liking beside Nestle.
Doldrums...., page-19
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.005(1.49%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.0¢ | 33.0¢ | $1.220M | 3.642M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 57289 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 52306 | 3 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |